Tag Archives: Aushon BioSystems

December 2017—Aushon BioSystems and ABL announced that ABL has adopted the Cira platform for multiplex and ultrasensitive biomarker analysis. ABL will offer this proprietary technology as a new addition to its service offerings in support of pharmaceutical and clinical research clients.

April 2017—Aushon BioSystems announced U.S. Patent No. 9,527,085, titled “Apparatus and method for dispensing fluid, semi-solid and solid samples,” was issued by the U.S. Patent and Trademark Office for microarray printing of complex biological and chemical fluids.

July 2016—Aushon BioSystems has launched the Ciraplex Ultra Ultrasensitive Assays with femtogram/milliliter level detection to address multiple biomarkers in a wide range of therapeutic areas.